Patent ID: 11965017
Assignee: INHIBRX, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. The method of claim 2, wherein the subject has a disease or disorder selected from the following: alpha-1 antitrypsin (AAT) deficiency, an infection, emphysema, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), allergic asthma, cystic fibrosis, cancers of the lung, ischemia-reperfusion injury, ischemia/reperfusion injury following cardiac transplantation, myocardial infarction, rheumatoid arthritis, septic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, type I diabetes, type II diabetes, pneumonia, sepsis, graft versus host disease (GVHD), a wound, systemic lupus erythematosus, and multiple sclerosis.